Frontline Blog

Big cities see slowing trend in drug overdose deaths

August 2024

Graphic that shows a bar chart with rising numbers and text that reads: "2022 overdose deaths in big cities"
SHARE THIS
TwitterLinkedInFacebookEmail

The most recent city-level data show that the alarming increases in drug overdose deaths from 2020 and 2021 have slowed and may be reversing. Big city health departments need stronger support to continue this positive trend.

The data show some encouraging signs that the overdose death trend may be reversing. In 2022, big cities saw a smaller increase in overdose deaths (as seen in the graph above), and in 2023 the U.S. as a whole experienced a decrease in overdose deaths. (City-level data for 2023 are not yet available.)

Big city health departments play an important role in responding to the overdose epidemic. The dramatic increase in the supply of fentanyl – a drug that is both inexpensive and can cause overdose even in minuscule amounts – has created a particularly challenging environment.

We are in a critical moment: more investment in evidence-based strategies for overdose prevention and related supports such as low-barrier housing would help keep the recent data trend moving in the right direction.

The right tools for the job

Multiple studies have demonstrated the effectiveness of public health overdose prevention strategies, including that they prevent deaths, prevent transmission of infectious diseases, reduce emergency department visits and other costly health care services, and offer people who use drugs more opportunities to connect to treatment and other health services in stigma-free settings.

Among the 35 member cities within the Big Cities Health Coalition (BCHC), each employs a combination of public health strategies to best address substance use and overdose in their communities. For instance, the Southern Nevada Health District (which serves Las Vegas and the surrounding county) was one of the first jurisdictions to use vending machines to distribute prevention supplies such as naloxone, fentanyl test strips, and sexual health kits. Public Health–Seattle & King County launched a major social media campaign to educate youth and adults about fentanyl and reduce stigma. And several cities, including Columbus, OH, have established Mobile Crisis Response Units to send public health clinicians alongside police for calls involving a mental health or substance use crisis. Our recent polling found that city residents overwhelmingly support such public health strategies to address drug overdose and related issues.

Subscribe to our newsletter

Ongoing disparities rooted in systemic racism

Graph showing that most large US cities have disproportionate overdose deaths for Black residents than for white residents

In 2010, white Americans had the highest drug overdose death rate. A decade later, Black Americans had the highest rate. The rise in overdose deaths among Black persons is thought to be rooted in three interrelated factors:

1. Racism in health care – Black patients not prescribed opioids for similar levels of pain that white patients experienced

For similar levels of pain, Black patients have been prescribed opioids at much lower doses (or not at all). Lower opioid prescriptions to Black patients partially protected them during the early period of the opioid epidemic that was fueled by over-prescribing; however, it also contributed to Black persons disproportionately replying on street drug supplies.

2. Rapid rise in illicit synthetic street opioids (and mixtures of drugs) that are more lethal than heroin

In recent years, drugs that are more lethal than heroin – illicit synthetic opioids and mixtures of drugs – have dramatically increased the risk of fatal overdose among those disproportionately reliant on street drugs.

3. Systemically lower access to health care treatment options

Black drug users have lower access to early intervention and health care treatment for addiction due to lower rates of employer-provided health insurance and wide variations in coverage whether by Medicaid or private insurance.

Federal policies needed to support local work

As big city health departments continue to address the overdose epidemic and work with their communities to create a healthy environment for everyone, specific policy changes at the federal level are needed to support their work:

  • Increase and sustain funding for programs at the Centers for Disease Control and Prevention (CDC) that directly support local efforts to conduct outreach, respond to infectious disease clusters associated with drug use, and link individuals to care.
  • Reduce regulatory barriers to medication-assisted treatments such as methadone and buprenorphine.
  • Invest in evidence-based interventions that will curb the HIV, viral hepatitis, and overdose crises.
  • Enhance opioid overdose prevention services, such as widescale distribution of naloxone to reverse overdoses.
  • Strengthen surveillance and early warning systems including community-based drug checking facilities. These can help detect emerging contaminants in the drug supply, motivate public health alerts, and provide resources to communities most in need.
  • Remove the federal funding ban on purchasing syringes and other drug paraphernalia for the prevention of infectious disease and overdose deaths.

About the data

To best implement public health tools like harm reduction, health departments require accurate and timely data. The Big Cities Health Inventory, an open-source platform providing health metrics for the cities that make up BCHC, allows health measures to be analyzed and compared across these localities. The Big Cities Health Coalition manages the platform in partnership with the Urban Health Collaborative at the Dornsife School of Public Health, Drexel University.

Visit our city data dashboard

The Big Cities Health Inventory data platform is primarily funded by the U.S. Centers for Disease Control and Prevention through a cooperative agreement with the National Association of County and City Health Officials. The views expressed on the data platform do not necessarily represent the views of the funders.

SHARE THIS
TwitterLinkedInFacebookEmail